Underpinning Endogeneous Damp EDA-Fibronectin in the Activation of Molecular Targets of Rheumatoid Arthritis and Identifcation of its Effective Inhibitors by Computational Methods-Reference-Cited by-同舟云学术

Underpinning Endogeneous Damp EDA-Fibronectin in the Activation of Molecular Targets of Rheumatoid Arthritis and Identifcation of its Effective Inhibitors by Computational Methods

Published:2023-03-28 Issue:11 Volume:195 Page:7037-7059
ISSN:0273-2289
Container-title:Applied Biochemistry and Biotechnology
language:en
Short-container-title:Appl Biochem Biotechnol

Author:

Sakthivel Premnath^ORCID,Sakthivel Indrajith^ORCID,Paramasivam Sivasakthi^ORCID,Perumal Senthamil Selvan^ORCID,Ekambaram Sanmuga Priya^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s12010-023-04451-8.pdf

Reference66 articles.

1. Guo, Q., Wang, Y., Xu, D., Nossent, J., Pavlos, N. J., & Xu, J. (2018). Rheumatoid arthritis: Pathological mechanisms and modern pharmacologic therapies. Bone Research, 6(1), 15. https://doi.org/10.1038/s41413-018-0016-9

2. Matcham, F., Scott, I. C., Rayner, L., Hotopf, M., Kingsley, G. H., Norton, S., & Steer, S. (2014). The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 44(2), 123–130. https://doi.org/10.1016/j.semarthrit.2014.05.001

3. Edwards, C. J., & Cooper, C. (2006). Early environmental factors and rheumatoid arthritis. Clinical and Experimental Immunology, 143(1), 1–5. https://doi.org/10.1111/j.1365-2249.2005.02940.x

4. Bullock, J., Rizvi, S. A. A., Saleh, A. M., Ahmed, S. S., Do, D. P., Ansari, R. A., & Ahmed, J. (2019). Rheumatoid arthritis: A brief overview of the treatment. Medical Principles and Practice, 27(6), 501–507. https://doi.org/10.1159/000493390

5. Tanaka, Y., Millson, D., Iwata, S., & Nakayamada, S. (2021). Safety and efficacy of fostamatinib in rheumatoid arthritis patients with an inadequate response to methotrexate in phase II OSKIRA-ASIA-1 and OSKIRA-ASIA-1X study. Rheumatology (United Kingdom), 60(6), 2884–2895. https://doi.org/10.1093/rheumatology/keaa732

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DAMPs and DAMP-sensing receptors in inflammation and diseases;Immunity;2024-04